The House of Representatives voted Thursday to cap monthly insulin costs at $35 for millions of diabetic Americans.
Lawmakers approved the measure in a 232-193 vote, with just a dozen Republicans joining Democrats in support. It now heads to the Senate.
The Affordable Insulin Now Act, which would take effect in 2023, would limit cost-sharing under private health insurance for a month’s supply of certain insulin products at $35, or 25 percent of a plan’s negotiated price, whichever is less.
According to the Centers for Disease Control and Prevention, 37.3 million people in the U.S. have diabetes.
Needless to say, Congressman Cline was not one of the 12 Republicans supporting the legislation.
For all of Cline’s professed concern about the “ever-increasing cost of prescription drugs” and rising prices in general, he was unwilling to help millions of the people who bear the brunt of those high costs.